Alzheimer's Disease Drug Industry Research Report 2024

Alzheimer's Disease Drug Industry Research Report 2024


Summary

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
According to APO Research, the global Alzheimer's Disease Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Alzheimer's Disease Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Alzheimer's Disease Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Alzheimer's Disease Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Alzheimer's Disease Drug include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Alzheimer's Disease Drug segment by Type

Donepezil
Memantine
Rivastigmine
Others
Alzheimer's Disease Drug segment by Application

Early to Moderate Stages
Moderate to Severe Stages
Alzheimer's Disease Drug Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer's Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alzheimer's Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer's Disease Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alzheimer's Disease Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Alzheimer's Disease Drug Market Size (2019-2030) & (US$ Million)
2.2.2 Global Alzheimer's Disease Drug Sales (2019-2030)
2.2.3 Global Alzheimer's Disease Drug Market Average Price (2019-2030)
2.3 Alzheimer's Disease Drug by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Donepezil
2.3.3 Memantine
2.3.4 Rivastigmine
2.3.5 Others
2.4 Alzheimer's Disease Drug by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Early to Moderate Stages
2.4.3 Moderate to Severe Stages
3 Market Competitive Landscape by Manufacturers
3.1 Global Alzheimer's Disease Drug Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Alzheimer's Disease Drug Sales (M Units) of Manufacturers (2019-2024)
3.3 Global Alzheimer's Disease Drug Revenue of Manufacturers (2019-2024)
3.4 Global Alzheimer's Disease Drug Average Price by Manufacturers (2019-2024)
3.5 Global Alzheimer's Disease Drug Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Alzheimer's Disease Drug, Product Type & Application
3.8 Global Manufacturers of Alzheimer's Disease Drug, Date of Enter into This Industry
3.9 Global Alzheimer's Disease Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Allergan
4.1.1 Allergan Company Information
4.1.2 Allergan Business Overview
4.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
4.1.5 Allergan Recent Developments
4.2 Eisai
4.2.1 Eisai Company Information
4.2.2 Eisai Business Overview
4.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
4.2.5 Eisai Recent Developments
4.3 Novartis
4.3.1 Novartis Company Information
4.3.2 Novartis Business Overview
4.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
4.3.5 Novartis Recent Developments
4.4 Daiichi Sankyo
4.4.1 Daiichi Sankyo Company Information
4.4.2 Daiichi Sankyo Business Overview
4.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
4.4.5 Daiichi Sankyo Recent Developments
4.5 Merz Pharma
4.5.1 Merz Pharma Company Information
4.5.2 Merz Pharma Business Overview
4.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
4.5.5 Merz Pharma Recent Developments
4.6 Pfizer
4.6.1 Pfizer Company Information
4.6.2 Pfizer Business Overview
4.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
4.6.5 Pfizer Recent Developments
4.7 Johnson & Johnson
4.7.1 Johnson & Johnson Company Information
4.7.2 Johnson & Johnson Business Overview
4.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
4.7.5 Johnson & Johnson Recent Developments
4.8 Lundbeck
4.8.1 Lundbeck Company Information
4.8.2 Lundbeck Business Overview
4.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
4.8.5 Lundbeck Recent Developments
5 Global Alzheimer's Disease Drug Market Scenario by Region
5.1 Global Alzheimer's Disease Drug Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Alzheimer's Disease Drug Sales by Region: 2019-2030
5.2.1 Global Alzheimer's Disease Drug Sales by Region: 2019-2024
5.2.2 Global Alzheimer's Disease Drug Sales by Region: 2025-2030
5.3 Global Alzheimer's Disease Drug Revenue by Region: 2019-2030
5.3.1 Global Alzheimer's Disease Drug Revenue by Region: 2019-2024
5.3.2 Global Alzheimer's Disease Drug Revenue by Region: 2025-2030
5.4 North America Alzheimer's Disease Drug Market Facts & Figures by Country
5.4.1 North America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Alzheimer's Disease Drug Sales by Country (2019-2030)
5.4.3 North America Alzheimer's Disease Drug Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
5.5.1 Europe Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Alzheimer's Disease Drug Sales by Country (2019-2030)
5.5.3 Europe Alzheimer's Disease Drug Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Alzheimer's Disease Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Alzheimer's Disease Drug Sales by Country (2019-2030)
5.6.3 Asia Pacific Alzheimer's Disease Drug Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
5.7.1 Latin America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Alzheimer's Disease Drug Sales by Country (2019-2030)
5.7.3 Latin America Alzheimer's Disease Drug Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.7.7 Colombia
5.8 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2019-2030)
5.8.3 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Alzheimer's Disease Drug Sales by Type (2019-2030)
6.1.1 Global Alzheimer's Disease Drug Sales by Type (2019-2030) & (M Units)
6.1.2 Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)
6.2 Global Alzheimer's Disease Drug Revenue by Type (2019-2030)
6.2.1 Global Alzheimer's Disease Drug Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)
6.3 Global Alzheimer's Disease Drug Price by Type (2019-2030)
7 Segment by Application
7.1 Global Alzheimer's Disease Drug Sales by Application (2019-2030)
7.1.1 Global Alzheimer's Disease Drug Sales by Application (2019-2030) & (M Units)
7.1.2 Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)
7.2 Global Alzheimer's Disease Drug Revenue by Application (2019-2030)
7.2.1 Global Alzheimer's Disease Drug Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)
7.3 Global Alzheimer's Disease Drug Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Alzheimer's Disease Drug Value Chain Analysis
8.1.1 Alzheimer's Disease Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Alzheimer's Disease Drug Production Mode & Process
8.2 Alzheimer's Disease Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Alzheimer's Disease Drug Distributors
8.2.3 Alzheimer's Disease Drug Customers
9 Global Alzheimer's Disease Drug Analyzing Market Dynamics
9.1 Alzheimer's Disease Drug Industry Trends
9.2 Alzheimer's Disease Drug Industry Drivers
9.3 Alzheimer's Disease Drug Industry Opportunities and Challenges
9.4 Alzheimer's Disease Drug Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings